Skip to main content
Fig. 4 | Journal of Neuroinflammation

Fig. 4

From: Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson’s disease

Fig. 4

Expression of NADSYN1 and NMNAT in different regions in PD patients. A Nicotinic acid and nicotinamide metabolic pathways in KEGG database (map00760, NAD+ anabolic pathway in red, M00115). B Differential mRNA expression of NMNAT1, NMNAT2, and NMNAT3 in PD patients (n = 16) and healthy individuals (n = 9) in microarray dataset GSE7621. C Differential expression of NADSYN1 mRNA in PD patients (n = 16) and healthy individuals (n = 9) in microarray dataset GSE7621. D Differential expression of NMNAT2 mRNA in PD patients (n = 14) and healthy individuals (n = 15) in microarray dataset GSE20168. E Differential expression of NMNAT2 mRNA of in PD patients (n = 15) and healthy individuals (n = 20) in microarray dataset GSE20291

Back to article page